Principal Investigators

19Apr201220217gcmqe4c3ff

Current Study Site Models

by Jae Chung

What type of site are you?  There are many types of study sites and business models they work under. Do you know what they all are, what their differentiating features are, and under what circumstances each type might (or might not) be advantageous to you when selecting sites? Are you an ISN? One type of [...]

{ 7 comments }

12Apr201247103zf7ql3qmz9

Wearing the CROWN of site startup

by Todd Tullis

ExL Pharma’s Clinical Research Operations and Worldwide Networking Summit (CROWN) for 2012 took place in Phildelphia, PA in mid-March. The CROWN event is a combination of five conferences, all co-located in one networking hall, with individual session rooms for each. goBalto sponsored one of the five conferences which was focused on clinical site feasibility, selection, and [...]

{ 0 comments }

By: Sherry Reuter  A frank discussion about studies An interesting discussion has taken place over the last month on LinkedIn in the The Association of Clinical Research Professionals group (view discussion here).  I thought it would be of interest to many study sites (as well as sponsors and CROs) so have posted some of the 65 [...]

{ 19 comments }

Status quo and how things are changing Performing 100% Source Document Verification (SDV) has been the gold standard for years in clinical research.  CRAs spent much of their careers checking every datapoint on CRFs against Source Data. But change is here. The amount of SDV checked has decreased from 85% in Q2 2007 to just [...]

{ 3 comments }

goBalto takes London Last week, I had the pleasure of speaking at one of Informa’s latest conferences in London, England: Site Feasibility and Study Start Up. For me, the first milestone was when I boarded my first flight to Heathrow. Even with 80+ mph winds at our rear and a 3 hour shorter flight than [...]

{ 3 comments }

19Dec2011Screen shot 2011-12-05 at 9.49.50 AM

When in Doubt – Ask!

by Jae Chung

I was talking to a colleague who manages a study site about situations in which sites and sponsors might seem to be far apart and how that affects the clinical research enterprise. Most importantly, what, if anything, can be done in those cases? The situation presents itself… A common example this site manager cited is [...]

{ 0 comments }

We’ve combed through the past 3 years worth of archived posts and came up with our most popular articles by topic. There were plenty to choose from, but in the end – YOU – the reader told us what you found most interesting. Here they are for your reading pleasure. Hope you enjoy them! Clinical [...]

{ 0 comments }

The burden of running a trial today. Study sites are key to the success of clinical research. After all, they are the link to the study subject, conduct the protocol and provide the data from the trial. Like marathon runners constantly in motion, they are incredibly busy with the numerous tasks involved in conducting trials [...]

{ 0 comments }

Ambitious. This is the word I would use to describe the 50/7/2 experiment. goBalto collaborated with a global pharmaceutical company and leading clinical research organization (CRO) to initiate Fifty sites on a mock study in Seven days across Two continents using our web-based site initiation tool – Tracker. We collectively pushed the “envelope” intentionally, to see [...]

{ 1 comment }

Authored by Sherry Reuter The follow up… A few weeks ago, one reader commented on the list posted from my interview with a study subject, saying she: “ …wished the patient had gone into more detail on some of her positive experiences. While we can continue to learn from these awful experiences, none of us [...]

{ 4 comments }